Listening to Lyrica: Contested illnesses and pharmaceutical determinism

Social Science and Medicine

Volumn 73, Issue 6, 2011, Pages 833-842

  Barker, Kristin K ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Contested illnesses; Direct to consumer advertising; Fibromyalgia; Gender; Medicalization; Medications; USA

Indexed keywords

GABAPENTIN; PREGABALIN;

ADVERTISING; DRUG; GENDER ISSUE; PUBLIC HEALTH;

ARTICLE; ATTITUDE TO ILLNESS; AWARENESS; CONSUMER ADVOCACY; CONSUMER ATTITUDE; CONSUMER HEALTH INFORMATION; CULTURAL FACTOR; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG PACKAGING; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; HUMAN; LEGAL ASPECT; PAIN ASSESSMENT; PHARMACEUTICAL CARE; PRESCRIPTION; SEX DIFFERENCE;

ANALGESICS; DRUG APPROVAL; DRUG INDUSTRY; FIBROMYALGIA; GAMMA-AMINOBUTYRIC ACID; HUMANS; MARKETING OF HEALTH SERVICES; SEX FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

UNITED STATES;

EID: 80052269592     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2011.05.055     Document Type: Article

References (62)

1. Angell M. The truth about the drug companies: how they deceive us and what to do about it 2004, Random House, New York.
2. Arnold L.M., Russell I.J., Diri E.W., Duan W.R., Young J.P.J., Sharma U., et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. The Journal of Pain 2008, 9(9):792-805.
3. Barker K. The fibromyalgia story: medical authority and women's worlds of pain 2005, Temple University Press, Philadelphia.
4. Barker K. Electronic support groups, patient-consumers, and medicalization: the case of contested illness. Journal of Health and Social Behavior 2008, 49(1):20-36.
5. Barsky A., Borus J. Somatization and medicalization in the era of managed care. JAMA 1995, 274(24):1931-1934.
6. Barsky A., Borus J. Functional somatic syndromes. Annals of Internal Medicine 1999, 130(11):910-921.
7. Berenson A. Drug approved. is disease real 2008, Retrieved, The New York Times. http://www.nytimes.com/2008/01/14/health/14pain.html%3F_r%3D1&em&ex=1200459600&en=bac45d5aff5a17d7&ei%3D5087%250A&oref%3Dslogin.
8. Bird C., Rieker P.P. Gender and health: the effects of constrained choice and social policies 2008, Cambridge University Press, New York.
9. Bonaccorso S.N., Sturchio J.L. Direct to consumer advertising is medicalising normal human experience, against. British Medical Journal 2002, 324:910-911.
10. Cohen M. Is fibromyalgia a distinct clinical entity? The disapproving rheumatologist's evidence. Bailliere's Clinical Rheumatology 1999, 12(3):421-425.
11. Conrad P. The shifting engines of medicalization. Journal of Health and Social Behavior 2005, 46:3-14.
12. Conrad P. The medicalization of society: on the transformation of human conditions into treatable disorders 2007, The Johns Hopkins University Press, Baltimore, Maryland.
13. Conrad P., Leiter V. From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation. Sociology of Health and Illness 2008, 30(6):825-838.
14. Conrad P., Stults C. Contestation and medicalization. Contesting illness: Processes and practice 2008, 323-335. University of Toronto Press, Toronto. P. Moss, K. Teghtsoonian (Eds.).
15. Crofford L.J., Mease P.J., Simpson S.L., Young J.P.J., Martin S.A., Haig G.M., et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008, 136(3):419-431.
16. Crofford L.J., Rowbotham M.C., Mease P.J., Russell I.J., Dworkin R.H., Corbin A.E., et al. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism 2005, 52(4).
17. Csillag C. Fibromyalgia: The Copenhagen declaration. Lancet 1992, 340(8820):663-664.
18. Davis J.E. Medicalization, social control, and the relief of suffering. The new blackwell companion to medical sociology 2009, 211-241. Blackwell Publishers, Malden, MA. W.C. Cockerham (Ed.).
19. Donohue J.M., Cevasco M., Rosenthal M.B. A decade of direct-to-consumer advertising of prescription drugs. The New England Journal of Medicine 2007, 357(7):673-681.
20. Doyal L. What makes women sick: gender and the political economy of health 1995, Rutgers University Press, New Brunswick, NJ.
21. Fox N.J., Ward K.J. Pharma in the bedroom. and the kitchen. The pharmaceuticalisation of daily life. Sociology of Health and Illness 2008, 30(6):856-868.
22. Frosch D.L., Krueger P.M., Hornik R.C., Cronholm P.F., Barg F.K. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Annals of Family Medicine 2007, 5(1):6-13.
23. Goldenberg D.L., Burckhardt C., Crofford L.J. Management of fibromyalgia syndrome. Journal of the American Medical Association(JAMA) 2004, 292:2388-2395.
24. Greene J. Prescribing by the numbers: drugs and the definition of disease 2007, The Johns Hopkins University Press, Baltimore, MD.
25. Hadler N.M. La maladie est morte, vive le malade. Journal of Rheumatology 1997, 24(7):1250-1251.
26. Hadler N.M., Greenhalgh S. Labeling woefulness: the social construction of fibromyalgia. Spine 2005, 30:1-4.
27. Hohenberg K.W., Wilson A., Daley T.L., Fam S.R. Fibromyalgia 2007, Waltham, MA. http://www.dresources.com/Products-and-Services/Report%3Fr%3Dpcorpn0108.
28. Joyce K.A. Magnetic appeal: MRI and the myth of transparency 2008, Cornell University Press, Ithaca, NY.
29. Jutel A. Sociology of diagnosis: a preliminary review. Sociology of Health and Illness 2009, 31(2):278-299.
30. Lakoff A. Pharmaceutical reason: knowledge and value in global psychiatry 2006, Cambridge University Press, Cambridge.
31. Loe M. The rise of viagra: how the little blue pill changed sex in America 2004, New York University Press, New York.
32. Lorber J. Gender and the social construction of illness 1997, Sage Publishing, Thousand Oaks, CA.
33. Manu P. The psychopathology of functional somatic syndromes: neurobiology and illness behavior in chronic fatigue syndrome, fibromyalgia, gulf war illness, irritable bowel, and premenstrual dysphoria 2004, Haworth Medical Press, New York.
34. Matallana L. National fibromyalgia association applauds FDA approval of lyrica 2007, Retrieved on June 5, 2010, National Fibromyalgia Association. http://www.fmaware.org/site/News2%3Fpage%3DNewsArticle%26id%3D5632.
35. Milton C. Is fibromyalgia a distinct clinical entity? The disapproving rheumatologist's evidence. Bailliere's Clinical Rheumatology 1999, 13(3):421-425.
36. Mintzes B. Direct to consumer advertising is medicalising normal human experience, for. British Medical Journal 2002, 324:908-911.
37. Mintzes B., Barer M.L., Kravitz R.L., Kazanjian A., Bassett K., Lexchin J., et al. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. British Medical Journal 2002, 324:278-279.
38. Moss P., Teghtsoonian K. Contesting illness: processes and practices 2008, University of Toronto Press, Toronto.
39. Moynihan R., Cassels A. Selling sickness: how the world's biggest pharmaceutical companies are turning us all into patients 2005, Nation Books, New York.
40. Moynihan R., Heath I., Henry D. 'Selling sickness': the pharmaceutical industry and disease mongering. British Medical Journal 2002, 324:886-891.
41. Facing fibromyalgia, finding hope 2007, National Fibromyalgia Association.
42. Nettleton S. 'I just want permission to be ill': towards a sociology of medically unexplained symptoms. Social Science & Medicine 2006, 62(5):1167-1178.
43. Neumann L., Buskila D. Epidemiology of fibromyalgia. Current Pain and Headache Reports 2003, 7(5):362-368.
44. O'Reilly C., Capaccio T. Pfizer agrees to record criminal fine in fraud probe 2009, http://Bloomberg.com.
45. Payer L. Disease-mongers: how doctors, drug companies, and insurers are making you feel sick 1992, John Wiley and Sons, Inc, New York.
46. Pfizer Inc. (2008). Pfizer 2007 annual report. New York.
47. Pfizer Inc. (2009). Pfizer 2008 annual report. New York.
48. Pfizer Inc Lyrica, television commercial 2010, New York. http://www.lyrica.com/fibromyalgia_tv_commercial.aspx.
49. Pfizer Inc. (2010b). Pfizer 2009 annual report. New York.
50. Recla J.M. New and emerging therapeutic agents for the treatment of fibromyalgia: an update. Journal of Pain Research 2010, 22(3):89-103.
51. Riessman C.K. Narrative methods for the human sciences 2008, Sage, Thousand Oaks, CA.
52. Ruzek S.B., Olsen V., Clarke A. Women's health: complexities and differences 1997, Ohio State University Press, Columbus, OH.
53. Showalter E. Hystories: hysterical epidemics and modern media 1997, Columbia University Press, New York.
54. Spencer L., Ritchie J., O'Connor W. Analysis: practices, principles and processes. Qualitative research practice 2003, 199-218. Sage, Thousand Oaks, CA. J. Ritchie, J. Lewis (Eds.).
55. Tiefer L. Female sexual dysfunction: a case study of disease mongering and activist resistance. PLoS Med 2006, 3(4):e178.
56. Wessley S., Nimnuan C., Sharpe M. Functional somatic syndromes: one or many?. The Lancet 1999, 354(9182):936-939.
57. Williams S.J., Gabe J., Davis P. The sociology of pharmaceuticals: progress and prospects. Sociology of Health and Illness 2008, 30(6):813-824.
58. Williams S.J., Seale C., Boden S., Lowe P., Steinberg D.L. Waking up to sleepiness: modafinial, the media and the pharmaceuticalisation of everyday/night life. Sociology of Health and Illness 2008, 30(6):830-855.
59. Wolfe F. Fibromyalgia wars. The Journal of Rheumatology 2009, 36(4):671-678.
60. Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., Katz R.S., Mease P., et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Research 2010, 62(5):600-610.
61. Wolfe F., Michaud K. Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis. Journal of Rheumatology 2009, 36(4):831-836.
62. Wolfe F., Smythe H., Yunus M., Bennett R., Bombardier C., Goldenberg D., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis and Rheumatism 1990, 33(2):160-172.